Adults who started taking GLP-1 receptor agonist drugs such as semaglutide logged fewer daily steps and less time exercising ...

Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...

For years, GLP-1 drugs like Wegovy and Zepbound have transformed the discussion around obesity — but left millions locked out ...

Millions of Americans on Medicare will have access to prescription weight loss medications for the first time starting July 1 ...

Researchers found in a 2024 study that users of the drugs may face elevated risks of anxiety, depression and suicidal tendencies.

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. In a ...

The Isle of Man Government is considering whether access to weight-loss medication should be expanded, including the possible ...

New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...

For a little over a century, modern weight loss medications have worked to provide a slimming solution that mature adults can count on. Subsequently, reduction drugs such as glucagon-like peptide-1 ...